Sec. 20.1. (a) Each board member and each therapeutics committee member shall fully disclose any potential conflicts of interest, financial or otherwise, relating to an issue that comes before the board or committee for recommendation or other action.

     (b) A board member or therapeutics committee member may not vote on a recommendation or other action if the member or the member’s employer has a conflict of interest, financial or otherwise, in the outcome of the vote.

     (c) A board member or therapeutics committee member who may not vote on a recommendation or other action under subsection (b) may still participate in any discussions regarding the recommendation or other action.

As added by P.L.231-1999, SEC.4. Amended by P.L.107-2002, SEC.14.